Diagnostic imaging of lymph structures

a lymph node and lymph node technology, applied in the field of diagnosis imaging of lymph nodes, can solve the problems of poor uptake of agents into the lymph nodes, ineffectiveness, and insufficient retention of agents in the lymph nodes to stop their progress, and achieve the effects of improving visualization of afferent lymphatics and regional lymph nodes, easy detection and image, and improved visualization

Inactive Publication Date: 2002-05-23
RGT UNIV OF CALIFORNIA
View PDF0 Cites 31 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

0014] In a broad aspect, the present invention provides methods and systems for identifying and imaging lymphatic structures in a subject. To this end, the present invention preferably comprises the administration of contrast agents that are preferentially taken up by the lymphatic system and allow for enhanced visualization of the afferent lymphatics and regional lymph nodes. Unlike prior art imaging agents that have been used for such imaging purposes, contrast agents compatible with the present invention are not limited to relatively small particle sizes. Rather, preferred contrast agents of the present invention comprise microbubble preparations having mean

Problems solved by technology

As particles approach 1000 nm, their uptake into lymphatics is so poor that they become ineffective.
This technique, called direct lymphangiography, is performed to detect tumor deposits in lymph nodes but is limited to the few regions of the body where direct canulation of the lymph vessel is possible.
These agents, although phagocytosed, are not sufficiently retained in the lymph node to halt their progress and highlight several lymph nodes in the local chain.
However, because they lack the functionality of white blood cells, they can become trapped in the lymph node and grow.
Unfortunately, although certain patterns in the spread of tumors are recognized, these patterns are complicated.
The failure to identify sentinel nodes results from the fact that they are indistinguishable from breast tissue unless colored blue.
Unfortunately, the dye has unpredictable and rapid clearance, and, possibly, the drainage patte

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0097] The invention was put in practice using a rabbit model with a Vx2 tumor implanted by bolus injection in the calf. The popliteal fossa was imaged with a Siemens Sonoline Elegra scanner equiped with a 7MHz trasnducer and the enlarged lymph nodes identified. 0.5 mL of AF0150 (Alliance Pharmaceutical Corp.) was injected at the margin of the leg tumor nearest the popliteal fossa and another 0.5 ml injected in the foot pad of the affected leg using a 23 G needle. The popliteal lymph nodes were imaged with standard, wideband, and burst wideband sonography immediately after injection and during massage of the foot pad. The lymph vessel leading to the popliteal node could be recognized as an echogenic line leading to the node. This process could be repeated several times. The lymph node fed by this vessel was enhanced and complete filling was achieved with intermittent imaging with a delay of 5 to 10 seconds. The delay time required to fill the node increased as the experiment progres...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

In accordance with the present invention, there are provided methods for identifying the sentinel lymph node in a drainage field for a tissue or organ in a subject. In select embodiments, the invention allows for the identification of the first or sentinel lymph node that drains the tissue or organ, particularly those tissues associated with neoplastic or infectious diseases and disorders, and within the pertinent lymph drainage basin. Once the drainage basin from the tissue or organ, i.e., the sentinel lymph node, is identified, a pre-operative or intraoperative mapping of the affected lymphatic structure can be carried out with a contrast agent. Identification of the first or sentinel lymph node, on the most direct drainage pathway in the drainage field, can be accomplished by a variety of imaging techniques, including ultrasound, MRI, CT, nuclear and others. Moreover, once the lymphatic structure is identified as being associated with neoplastic or infectious diseases and disorders, the affected lymphatic structure can be removed surgically or by a suitable minimally invasive procedure to allow pathological analysis to be performed to determine whether certain diseases or disorders exist, without resort to more radical lymphadenectomy. Further, the agent can be made to carry diagnostic or therapeutic probes to be activated and/or delivered to the injection site or any part of the lymphatic pathway downstream from the injection site.

Description

[0001] In a broad aspect, the present invention is directed to methods of imaging lymphocytic structures. More particularly, the present invention advantageously uses contrast agents to identify and image lymphatic ducts, sentinel nodes and / or other lymph nodes by various means, including ultrasound and MRI.[0002] The lymphatic system is made of vessels or ducts that begin in tissues and are designed to carry lymph fluid to local lymph nodes where the fluid is filtered and processed and sent to the next lymph node down the line until the fluid reaches the thoracic duct where it enters the blood stream. Lymph vessels infiltrate all tissues and organs of the body. Lymph fluid is generated from capillaries which because of tissue motion and hydrostatic pressure, enters the lymph vessels carrying with it local and foreign substances and materials from the tissues. These local and foreign molecular, micromolecular and macromolecular substances include antigens, infectious agents, particl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K47/48A61K49/04
CPCA61K49/223Y10S977/929Y10S977/928A61K49/225
Inventor MATTREY, ROBERT F.
Owner RGT UNIV OF CALIFORNIA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products